Total Funding
80
59
Total FundingSeries B raised
Growth Score
-1 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36106
KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.
Michael Dixon: Chief Financial Officer- David Young: Co-Founder, Chief Executive Officer
About the Company
KisoJi Biotechnology is an early-stage biotechnology company developing antibodies for the treatment of various cancers. Unlike traditional industry methods, the full spectrum of antibody diversity can be identified and visualized, allowing for the pinpointing of clusters with desired characteristics and the optimization of lead candidate
selection. The antibody platform includes multi-species single-domain antibody transgenic mice, AI-driven antibody fingerprinting to find the best fit with specific epitopes on any target, and a toolkit for creating robust, easily manufacturable multi-specific antibodies.
